Sign In
Buy AGNPF
$0.0557
+0 (+0%)
At Close: Nov 17, 2025
Algernon Pharmaceuticals Earnings Calls
Aug 28, 2025
(Upcoming)
| Release date | Jan 27, 2026 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 8.75% |
May 31, 2025
| Release date | Jul 30, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Feb 28, 2025
| Release date | Apr 29, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0146 |
| Revenue estimate | - |
| Revenue actual | - |
Nov 28, 2024
| Release date | Jan 29, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0094 |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Algernon Pharmaceuticals
Below you can see how AGNPF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Nov 28, 2024
| Release date | Jan 29, 2025 |
| Price on release | $0.0617 |
| EPS estimate | - |
| EPS actual | -$0.0094 |
| Date | Price |
|---|---|
| Jan 23, 2025 | $0.0565 |
| Jan 24, 2025 | $0.0536 |
| Jan 27, 2025 | $0.0536 |
| Jan 28, 2025 | $0.0536 |
| Jan 29, 2025 | $0.0617 |
| Jan 30, 2025 | $0.0575 |
| Jan 31, 2025 | $0.0575 |
| Feb 03, 2025 | $0.0550 |
| Feb 04, 2025 | $0.0610 |
| 4 days before | 9.20% |
| 4 days after | -1.13% |
| On release day | -11.54% |
| Change in period | 7.96% |
Feb 28, 2025
| Release date | Apr 29, 2025 |
| Price on release | $0.0520 |
| EPS estimate | - |
| EPS actual | -$0.0146 |
| Date | Price |
|---|---|
| Apr 23, 2025 | $0.0520 |
| Apr 24, 2025 | $0.0520 |
| Apr 25, 2025 | $0.0520 |
| Apr 28, 2025 | $0.0520 |
| Apr 29, 2025 | $0.0520 |
| Apr 30, 2025 | $0.0520 |
| May 01, 2025 | $0.0520 |
| May 02, 2025 | $0.0590 |
| May 05, 2025 | $0.0590 |
| 4 days before | 0% |
| 4 days after | 13.38% |
| On release day | 0% |
| Change in period | 13.38% |
May 31, 2025
| Release date | Jul 30, 2025 |
| Price on release | $0.0465 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 24, 2025 | $0.0485 |
| Jul 25, 2025 | $0.0485 |
| Jul 28, 2025 | $0.0485 |
| Jul 29, 2025 | $0.0400 |
| Jul 30, 2025 | $0.0465 |
| Jul 31, 2025 | $0.0470 |
| Aug 01, 2025 | $0.0470 |
| Aug 04, 2025 | $0.0474 |
| Aug 05, 2025 | $0.0427 |
| 4 days before | -4.16% |
| 4 days after | -8.17% |
| On release day | 0.97% |
| Change in period | -12.00% |
Aug 28, 2025
(Upcoming)
| Release date | Jan 27, 2026 |
| Price on release | - |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 11, 2025 | $0.0522 |
| Nov 12, 2025 | $0.0522 |
| Nov 13, 2025 | $0.0556 |
| Nov 14, 2025 | $0.0557 |
| Nov 17, 2025 | $0.0557 |
Algernon Pharmaceuticals Earnings History
Earnings Calendar
FAQ
When is the earnings report for AGNPF?
Algernon Pharmaceuticals Inc. (AGNPF) has scheduled its earnings report for Jan 27, 2026 before the markets open.
What is the AGNPF price-to-earnings (P/E) ratio?
AGNPF P/E ratio as of Nov 17, 2025 (TTM) is -1.40.
What is the AGNPF EPS forecast?
The forecasted EPS (Earnings Per Share) for Algernon Pharmaceuticals Inc. (AGNPF) for the first fiscal quarter 2025 is $.
What are Algernon Pharmaceuticals Inc.'s retained earnings?
On its balance sheet, Algernon Pharmaceuticals Inc. reported retained earnings of $0 for the latest quarter ending May 31, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
